HOME Research Insight Zoetis (US), Merck Animal Health (US), Elanco (US), Boehringer Ingelheim (Germany), Ceva (France), Phibro Animal Health (US), and Virbac Group (France) are the Major Players Contributing to the Global Veterinary Vaccines Market



Zoetis (US), Merck Animal Health (US), Elanco (US), Boehringer Ingelheim (Germany), Ceva (France), Phibro Animal Health (US), and Virbac Group (France) are the Major Players Contributing to the Global Veterinary Vaccines Market


The global veterinary vaccines market is expected to reach USD 8.66 Billion by 2022 from USD 6.50 Billion in 2017, at a CAGR of 5.9%. The growth of this market can be attributed to the growth in livestock population and repeated breakouts of livestock diseases; increasing adoption of companion animals; rising incidence of zoonotic diseases; initiatives by various government agencies, animal associations, and leading players; and the introduction of new types of vaccines.

Product launches remain at the center of the strategic growth initiatives adopted by a majority of key players in the global veterinary vaccines market. Companies such as Zoetis, Merck Animal Health, Boehringer Ingelheim, and Hipra have been focusing on product launches to enhance their market presence in recent years. Players also focused on increasing their presence in high-growth markets through inorganic growth strategies such as partnerships, collaborations, agreements, expansions, and acquisitions.

Zoetis is the dominant player in the global veterinary vaccines market. The company has an expansive range of veterinary vaccines and focuses on both organic and inorganic growth strategies such as product approvals, product launches, expansions, acquisitions, agreements, and collaborations to maintain its foothold in the market. The company has launched as many as thirteen products since 2014.

Merck Animal Health is another prominent player in this market. The company focuses on organic growth strategies (such as product launches and expansions) and inorganic strategies (such as acquisitions, partnerships, and collaborations). The company introduced fourteen products in the market from 2014 and acquired one company.

Boehringer Ingelheim is a key player in the global veterinary vaccines market. The company launched seven products in the market, in addition to adopting inorganic growth strategies such as acquisitions, collaborations, and partnerships. Boehringer Ingelheim has maintained its leadership position in the market through its wide product portfolio and significant market presence.

Some other leading players in the global veterinary vaccines market include Vetoquinol, Hester, Hipra, IDT Biologika, China Animal Husbandry, Biogenesis Bago, Tianjin Ringpu, and Jinyu Bio-technology. These companies have well-established sales and distribution networks across the globe. They also make significant investments in R&D activities to develop innovative technologies and products. Focus on innovation plays an important role in this market.

Related Reports:

Veterinary/Animal Vaccines Market by Type (Porcine, Poultry, Companion Animal, Aquaculture), Disease (Porcine Parvovirus, Swine Pneumonia, Avian Influenza, Rabies, Clostridial Diseases), Technology (Inactivated, Toxoid, Recombinant) - Global Forecast to 2022

Contact:
Mr. Rohan
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

Connect Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441

Search reports